1,026 Experimental treatments in acute stroke
By V. O'Collins, M. Macleod, G. Donnan, L. Horky, Bart Van Der Worp, D. Howells. Annals of Neurology, 2006
1,431 citations recorded by the source corpus.
Subfields: Epidemiology, Neurology, Small Animals
View Paper: https://www.semanticscholar.org/paper/470da64f5b8e34973555b2c8d443468b312ede3e
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Epidemiology
In Neurology
In Small Animals
Citations in the corpus
- Neuroprotection for ischemic stroke: past, present and future. (2008, methodology): “Among 66 agents (other than thrombolytics and anti-thrombotics) that they considered, the mean (± SD) overall extent of tissue protection for the group was a modest 31 ± 19% (O'Collins et al., 2006).”
- Animal models of ischemic stroke and their application in clinical research (2015, neutral): “…drug targets, as discussed in Moskowitz et al. 108 A large number of agents have revealed neuroprotective efficacy in preclinical studies but have failed to translate to efficacious therapies, irrespective of whether neuroprotective drugs were administered as a single agent 8 or in combination.”
- New Perspectives on How to Discover Drugs from Herbal Medicines: CAM's Outstanding Contribution to Modern Therapeutics (2013, background): “gene therapy as a novel pharmaceutical intervention [168, 169].”